Professor Margaret Riley presented a talk at The Institute of Medicines 2014 Richard & Hinda Rosenthal Symposium, in Washington DC. The Symposium explored the current and future impact of antimicrobial resistance, implications for our nation's health and that of the world, and obstacles and successes in the development of solutions and steps to mitigate this global public health challenge.
The Symposium was presented by The Institute of Medicine's Executive Office Board and covered a range of topics from: Health Care Workforce, Health Services, Coverage, Access, Public Health, Quality and Patient Safety.
Using UTI (urinary tract infection) as a model case, Riley and colleagues investigated the use of bacteriocin toxins as a potential treatment method. These antimicrobial molecules have been found to be effective against UTI-causing bacteria while being non-toxic to human cells.
The full video presentation appearing on The Institute of Medicines, of The National Academies, can be accessed here.
Department of Biology